Monarch’s New EndoTool Community Provides Clients the Ability to Collaborate, Access Resources and Manage Support Requests.
Charlotte, N.C., February 12, 2019 –Monarch Medical Technologies, the leader in precision insulin dosing for optimized inpatient glucose management, today announced the launch of the EndoTool Community, a portal designed to make it easier to access information and resources to optimize the use of the EndoTool Glucose Management System. Available for the first time to any EndoTool clients, the portal provides the ability to research relevant topics, interact with other users, and pose questions to both the Monarch team and other client organizations.
“At Monarch, we always strive to improve the user experience in both our software and in the services and support that we offer to our partners,” said Linda Beneze, President & CEO of Monarch Medical Technologies. “The EndoTool Community was requested by customers at our annual user group meeting asking for an online forum to exchange ideas and ask questions. We are excited to be able to provide this platform that not only allows open discussion at any time, but also provides access to all product resources in one place. It is a secure and confidential channel to submit and track cases working with the Monarch team.”
The EndoTool Community capabilities include:
- Access to all product and educational documents, presentations, and videos
- Means to ask or answer a question in an open forum with discussion topic by product and general glucose management trends and guidelines
- Ability to open a new support case, check on the current status of existing support cases, and view historical support cases
Monarch clients can sign up to join the community by visiting: http://info.monarchmedtech.com/communityportal.
About Monarch Medical Technologies
Monarch Medical Technologies is the leading provider of electronic systems for inpatient glycemic management. Monarch’s EndoTool® Glucose Management System offers personalized dosing recommendations for intravenous and subcutaneous insulin therapy. As a Class II FDA-cleared, patented software suite, EndoTool has enabled more than 260 hospitals to provide unsurpassed patient-specific glycemic control across a broad population of patients, and ultimately deliver better, safer care. For more information, please visit https://monarchmedtech.com.